On 2026-09-08, Braveheart Bio, Inc. (BRVE) announced earnings per share of $-2.51 for the fiscal quarter ending 2026-06-30, missing the average analyst estimate of $-0.25.

The next expected annoucement date for quarterly earnings is 2026-12-08, with an average estimated earnings per share of $-0.66 for the fiscal quarter ending 2026-09-30.

Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.